$5650 | Single User
$6650 | Multi User
$8150 | Corporate License
$10000 | Global License

In situ Hybridization Market by Type( DNA,RNA), Application (Cancer Diagnosis, Cytology, Immunology), End User (Hospitals, Pharma & Biotech, Research Labs) & by Geography - Analysis and Forecast to 2019
[Published by MarketsandMarkets]

Published by MarketsandMarkets: 13 Aug 2015 | 41844 | In Stock
Related Topics: Abbott , Roche

Introduction

In-situ hybridization (ISH) is a powerful technique used for focusing on specific nucleic acid targets within fixed tissues and cells, to obtain temporal and spatial information about gene expression. The in-situ hybridization technique is divided into two types, namely DNA and RNA. This is because, normally ISH requires isolation of DNA or RNA which is done by separating it on a gel, blotting it onto nitrocellulose, and probing it with a complementary sequence.

The global in-situ hybridization market was valued at 4.4 million 2014, and is estimated to reach 1.0 million by 2019, at a CAGR of 4.2% from 2014 to 2019.

The global in-situ hybridization market is primarily driven by the increasing prevalence of cancer disease, growing usage of personalized medicines for its treatment, and rising number of initiatives undertaken by the government, such as create awareness about cancer and providing funding to support related researches.

The report includes company profiles of major players, recent activities in the market, new product launches, mergers & acquisitions, collaborations and partnerships, and SWOT analysis.

Some of the companies profiled in this report are Abbott (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Affymetrix, Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), and Agilent Technologies, Inc. (U.S.).

Reasons to Buy the Report:

From an insight perspective, this research report has focused on various levels of analysis—industry analysis (industry trends, and PEST analysis), market share analysis of top players, supply chain analysis, and company profiles, which together comprise and discuss the basic views on the competitive landscape, usage patterns, emerging- and high-growth segments of the global in-situ hybridization market, high-growth regions and countries and their respective regulatory policies, government initiatives, drivers, restraints, and opportunities.

The report will enrich both established firms as well as new entrants/smaller firms to analyze the market, which in turn will help the firms in achieving greater market share. Firms purchasing the report could use any one or combination of the below mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market share.

The report provides insights on the following pointers:

• Product Analysis and development: Detailed insights on upcoming technologies, research and development activities, and new product launches in the global in-situ hybridization market. Usage pattern/ penetration rate (in-depth trend analysis) of products (Segment wise) and purchasing data. Comprehensive coverage of product approvals, pipeline products, and product recalls.

• Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for in-situ hybridization across geographies, exploit new distribution channels, new clientele base, and different pricing policies.

• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments decisions in the global in-situ hybridization market. Detailed description regarding the related and unrelated diversification pertaining to this market.

• Competitive Assessment: In-depth assessment of market shares, company share analysis of the key players forecasted till 2019. Develop business strategies and manufacturing capabilities of leading players enhance the bottom line of the companies operational in the global in-situ hybridization market.

Table of Contents
for In situ Hybridization Market by Type( DNA,RNA), Application (Cancer Diagnosis, Cytology, Immunology), End User (Hospitals, Pharma & Biotech, Research Labs) & by Geography - Analysis and Forecast to 2019 [Published by MarketsandMarkets]

  • TABLE OF CONTENTS

    1. INTRODUCTION

    2. EXECUTIVE SUMMARY

    3. MARKET OVERVIEW

    4 MARKET DYNAMICS

    5 IN-SITU HYBRIDIZATION MARKET, BY TYPE

    6 IN-SITU HYBRIDIZATION MARKET, BY APPLICATION

    7 IN-SITU HYBRIDIZATION MARKET, BY END USER

    8 IN-SITU HYBRIDIZATION MARKET, BY GEOGRAPHY

    9 COMPETITIVE LANDSCAPE

    10 COMPANY PROFILES

    10.1 ABBOTT

    10.2 BIOGENEX

    10.3 BIOSB

    10.4 F. HOFFMANN-LA ROCHE LTD

    10.5 SIGMA-ALDRICH CO. LLC.

    10.6 ADVANCED CELL DIAGNOSTICS

    10.7 AFFYMETRIX, INC.

    10.8 EXIQON A/S

    10.9 AGILENT TECHNOLOGIES

    10.10 THERMO FISHER SCIENTIFIC, INC.

    11 APPENDIX

List Of Tables
in In situ Hybridization Market by Type( DNA,RNA), Application (Cancer Diagnosis, Cytology, Immunology), End User (Hospitals, Pharma & Biotech, Research Labs) & by Geography - Analysis and Forecast to 2019 [Published by MarketsandMarkets]

LIST OF TABLES



5.1 IN-SITU HYBRIDIZATION MARKET, BY TYPE, 2012-2019 (USD MN)

5.2 DNA IN-SITU HYBRIDIZATION MARKET, BY GEOGRAPHY, 2012-2019 (USD MN)

5.3 DNA FLUORESCENT IN-SITU HYBRIDIZATION MARKET, BY GEOGRAPHY,

2012-2019 (USD MN)

5.4 DNA CHROMOGENIC IN-SITU HYBRIDIZATION MARKET, BY GEOGRAPHY,

2012-2019 (USD MN)

5.5 RNA IN-SITU HYBRIDIZATION MARKET, BY GEOGRAPHY, 2012-2019 (USD MN)

5.6 RNA FLUORESCENT IN-SITU HYBRIDIZATION (FISH) MARKET, BY GEOGRAPHY,

2012-2019 (USD MN)

5.7 RNA CHROMOGENIC IN-SITU HYBRIDIZATION (CISH) MARKET, BY GEOGRAPHY,

2012-2019 (USD MN)

6.1 IN-SITU HYBRIDIZATION MARKET, BY APPLICATION, 2012-2019 (USD MN)

6.2 CANCER DIAGNOSTICS MARKET, BY GEOGRAPHY, 2012-2019 (USD MN)

6.3 CYTOLOGY MARKET, BY GEOGRAPHY, 2012-2019 (USD MN)

6.4 NEUROSCIENCE MARKET, BY GEOGRAPHY, 2012-2019 (USD MN)

6.5 IMMUNOLOGY MARKET, BY GEOGRAPHY, 2012-2019 (USD MN)

6.6 OTHER APPLICATIONS MARKET, BY GEOGRAPHY, 2012-2019 (USD MN)

7.1 IN-SITU HYBRIDIZATION MARKET, BY END USER, 2012 - 2019 (USD MN)

7.2 HOSPITAL MARKET, BY GEOGRAPHY, 2012-2019 (USD MN)

7.3 PHARMA & BIOTECH COMPANIES MARKET, BY GEOGRAPHY, 2012-2019 (USD MN)

7.4 RESEARCH LABS MARKET, BY GEOGRAPHY, 2012-2019 (USD MN)

7.5 CROS MARKET, BY GEOGRAPHY, 2012-2019 (USD MN)

7.6 OTHER END USER MARKET, BY GEOGRAPHY, 2012-2019 (USD MN)

8.1 IN-SITU HYBRIDIZATION MARKET, BY GEOGRAPHY, 2012-2019 (USD MN)

8.2 NORTH AMERICA IN-SITU HYBRIDIZATION MARKET, BY TYPE, 2012-2019 (USD MN)

8.3 NORTH AMERICA DNA IN-SITU HYBRIDIZATION MARKET, BY TECHNIQUE,

2012-2019 (USD MN)

8.4 NORTH AMERICA RNA IN-SITU HYBRIDIZATION MARKET, BY TECHNIQUE,

2012-2019 (USD MN)

8.5 NORTH AMERICA IN-SITU HYBRIDIZATION MARKET, BY APPLICATION,

2012-2019 (USD MN)

8.6 NORTH AMERICA IN-SITU HYBRIDIZATION MARKET, BY END USER,

2012-2019 (USD MN)

8.7 EUROPE IN-SITU HYBRIDIZATION MARKET, BY TYPE, 2012-2019 (USD MN)

8.8 EUROPE DNA IN-SITU HYBRIDIZATION MARKET, BY TECHNIQUE,

2012-2019 (USD MN)

8.9 EUROPE RNA IN-SITU HYBRIDIZATION MARKET, BY TECHNIQUE,

2012-2019 (USD MN)

8.10 EUROPE IN-SITU HYBRIDIZATION MARKET, BY APPLICATION, 2012-2019 (USD MN)

8.11 EUROPE IN-SITU HYBRIDIZATION MARKET, BY END USER, 2012- 2019 (USD MN)

8.12 APAC IN-SITU HYBRIDIZATION MARKET, BY TYPE, 2012- 2019 (USD MN)

8.13 APAC DNA IN-SITU HYBRIDIZATION MARKET, BY TECHNIQUE,

2012- 2019 (USD MN)

8.14 APAC RNA IN-SITU HYBRIDIZATION MARKET, BY TECHNIQUE, 2012-2019 (USD MN)

8.15 APAC IN-SITU HYBRIDIZATION MARKET, BY APPLICATION, 2012-2019 (USD MN)

8.16 APAC IN-SITU HYBRIDIZATION MARKET, BY END USER, 2012-2019 (USD MN)

8.17 ROW IN-SITU HYBRIDIZATION MARKET, BY TYPE, 2012- 2019 (USD MN)

8.18 ROW DNA IN-SITU HYBRIDIZATION MARKET, BY TECHNIQUE, 2012-2019 (USD MN)

8.19 ROW RNA IN-SITU HYBRIDIZATION MARKET, BY TECHNIQUE, 2012-2019 (USD MN)

8.20 ROW IN-SITU HYBRIDIZATION MARKET, BY APPLICATION, 2012-2019 (USD MN)

8.21 ROW IN-SITU HYBRIDIZATION MARKET, BY END USER, 2012- 2019 (USD MN)

List Of Figures, Charts and Diagrams
in In situ Hybridization Market by Type( DNA,RNA), Application (Cancer Diagnosis, Cytology, Immunology), End User (Hospitals, Pharma & Biotech, Research Labs) & by Geography - Analysis and Forecast to 2019 [Published by MarketsandMarkets]

LIST OF FIGURES


2.1 IN-SITU HYBRIDIZATION MARKET SIZE, 2014 & 2019

2.2 IN-SITU HYBRIDIZATION MARKET SIZE, 2014 & 2019

2.3 IN-SITU HYBRIDIZATION MARKET SIZE, 2014 & 2019

3.1 IN-SITU HYBRIDIZATION MARKET SIZE, 2014 & 2019 (USD MN)

3.2 IN-SITU HYBRIDIZATION MARKET, BY TYPE, 2014 & 2019 (USD MN)

3.3 DNA IN-SITU HYBRIDIZATION MARKET, BY TECHNIQUE, 2014 & 2019 (USD MN)

3.4 RNA IN-SITU HYBRIDIZATION MARKET, BY TECHNIQUE, 2014 & 2019 (USD MN)

3.5 IN-SITU HYBRIDIZATION MARKET, BY APPLICATION, 2014 & 2019 (USD MN)

3.6 IN-SITU HYBRIDIZATION MARKET, BY END-USER, 2014 & 2019 (USD MN)

5.1 IN-SITU HYBRIDIZATION MARKET, BY TYPE, 2014 & 2019 (USD MN)

5.2 DNA IN-SITU HYBRIDIZATION MARKET, BY GEOGRAPHY, 2012 - 2019 (USD MN)

5.3 DNA FLUORESCENT IN-SITU HYBRIDIZATION MARKET, BY GEOGRAPHY,

2012 - 2019 (USD MN)

5.4 DNA CHROMOGENIC IN-SITU HYBRIDIZATION MARKET, BY GEOGRAPHY,

2012 - 2019 (USD MN)

5.5 RNA IN-SITU HYBRIDIZATION MARKET, BY GEOGRAPHY, 2012 - 2019 (USD MN)

5.6 RNA FLUORESCENT IN-SITU HYBRIDIZATION (FISH) MARKET, BY GEOGRAPHY, 2012 - 2019 (USD MN)

5.7 RNA CHROMOGENIC IN-SITU HYBRIDIZATION (CISH) MARKET, BY GEOGRAPHY, 2012 - 2019 (USD MN)

6.1 IN-SITU HYBRIDIZATION MARKET, BY APPLICATION, 2014 & 2019 (USD MN)

6.2 IN-SITU HYBRIDIZATION MARKET, BY APPLICATION, 2014 & 2019 (USD MN)

6.3 CANCER DIAGNOSTICS MARKET, BY GEOGRAPHY, 2012 - 2019 (USD MN)

6.4 CYTOLOGY MARKET, BY GEOGRAPHY, 2012 - 2019 (USD MN)

6.5 NEUROSCIENCE MARKET, BY GEOGRAPHY, 2012 - 2019 (USD MN)

6.6 IMMUNOLOGY MARKET, BY GEOGRAPHY, 2012 - 2019 (USD MN)

6.7 OTHER APPLICATION MARKET, BY GEOGRAPHY, 2012 - 2019 (USD MN)

7.1 IN-SITU HYBRIDIZATION MARKET, BY END USER, 2012 - 2019 (USD MN)

7.2 END-USER MARKET, BY GEOGRAPHY, 2014 & 2019 (USD MN)

7.3 HOSPITALS MARKET, BY GEOGRAPHY, 2012 - 2019 (USD MN)

7.4 PHARMA & BIOTECH COMPANIES MARKET, BY GEOGRAPHY,

2012 - 2019 (USD MN)

7.5 RESEARCH LABS MARKET, BY GEOGRAPHY, 2012 - 2019 (USD MN)

7.6 CROS MARKET, BY GEOGRAPHY, 2012 - 2019 (USD MN)

7.7 OTHERS MARKET, BY GEOGRAPHY, 2012 - 2019 (USD MN)

8.1 IN-SITU HYBRIDIZATION MARKET, BY GEOGRAPHY, 2012 - 2019 (USD MN)

8.2 NORTH AMERICA IN-SITU HYBRIDIZATION MARKET, 2014 & 2019 (%)

8.3 EUROPE IN-SITU HYBRIDIZATION MARKET, 2014 & 2019 (%)

8.4 APAC IN-SITU HYBRIDIZATION MARKET, 2014 & 2019 (%)

8.5 ROW IN-SITU HYBRIDIZATION MARKET, 2014 & 2019 (%)

Additional Details

Publisher

MarketsandMarkets

Publisher Information

Reference

41844 | BT 3649

Number of Pages

182

Report Format

PDF

MarketsandMarkets Reports

Related Reports

TitleDate PublishedPrice fromMore Details
Global Ex Situ Presulfurizing Catalysts Market Research Report Forecast 2017 to 2022
Delivery of the Report will take 2-3 working days once order is placed.The Global Ex Situ Presulfuri...
29 Jun 2017 by S&P Consulting USD $2,800 More Info
Global Fluorescent In Situ Hybridization Probe (FISH Probe) Market Research Report Forecast 2017 to 2021
The Global Fluorescent In Situ Hybridization Probe (FISH Probe) Market Research Report Forecast 2017...
15 May 2017 by S&P Consulting USD $2,800 More Info
Global Fluorescence In Situ Hybridization Market Research Report Forecast 2017 to 2021
The Global Fluorescence In Situ Hybridization Market Research Report Forecast 2017-2021 is a valuabl...
27 Apr 2017 by S&P Consulting USD $2,800 More Info
In-Situ Hybridization Market: By Technology (FISH & CISH), By Application (Cancer Diagnosis, Immunology & Others), By End-User (Hospitals, Pharma & Biotech & Research Labs) & By Region-Forecast (2017-2025)
In-Situ Hybridization is a type of hybridization to localize a specific DNA or RNA sequence in a por...
16 Mar 2017 by Industry ARC USD $5,250 More Info
Molecular Cytogenetics Market by Product (Kit, Reagent, Probe, Consumable, Software, Service), Technique (In-Situ, FISH, Comparative Genomic Hybridization), Application (Cancer, Genetic), End User (Research Labs, Institutes) - Forecast to 2021
The molecular cytogenetics market is projected to reach USD 2.52 billion by 2021 from USD 1.55 billi...
26 Jan 2017 by MarketsandMarkets USD $5,650 More Info
In situ Hybridization Market by Technique (FISH, CISH), Application (Cancer Diagnosis, Neuroscience, Cytology, Infectious Disease), & End User (Molecular Diagnostic Laboratories, Academic And Research Institutions) - Global Forecast to 2021
The in situ hybridization market is projected to reach USD 739.9 million by 2021 from USD 557.1 mill...
18 Jan 2017 by MarketsandMarkets USD $5,650 More Info
Cancer/Tumor Profiling Market by Application (Diagnostic, Personalized Medicine, Research), Technique (Genomics, Proteomics, Metabolomics, Epigenetics),Technology (Next-generation Sequencing, qPCR, In-situ Hybridization, Microarray)- Forecast to 2021
The global Cancer/Tumor Profiling market is poised to reach USD 61.87 billion by 2021 from USD 25.82...
06 Dec 2016 by MarketsandMarkets USD $5,650 More Info
Cancer Diagnostics Market: By Product Type (Next-generation Sequencing, Microarrays, PCR, Flow Cytometry, In situ Hybridization, Immunohistochemistry, Imaging Instruments, & Biopsy), By Cancer Treated & By Geography-Forecast (2016-2021)
Cancer can be defined as abnormal division of cells in an uncontrollable fashion. This uncontrollabl...
25 Feb 2016 by Industry ARC USD $5,250 More Info
DNA Diagnostics Market: By Technology Type (Polymerase chain reaction (PCR), Microarrays, Lab-on-chip or biochips, In situ hybridization, Novel gene sequencing, Mass spectrometry), By Application (Detection of mutations, Detection of disease causing genes, Diagnosing monogenic disorders & Others) & By Region-Forecast (2016-2021)
DNA diagnostics is a pioneer technique which has modernized the field of medical diagnostics. Numero...
11 Jan 2016 by Industry ARC USD $5,250 More Info
Tissue Diagnostics Market by Technology (Immunohistochemistry, in Situ Hybridization, Digital pathology & Workflow, Special Staining), Disease (Breast Cancer, Gastric Cancer), Product, and End Users & Region - Global Forecast to 2020
The global tissue diagnostics market is valued at USD 3,202.5 million in 2015 and expected to reach ...
02 Dec 2015 by MarketsandMarkets USD $5,650 More Info

This report is published by MarketsandMarkets

Download Free Report Summary PDF

In situ Hybridization Market by Type( DNA,RNA), Application (Cancer Diagnosis, Cytology, Immunology), End User (Hospitals, Pharma & Biotech, Research Labs) & by Geography - Analysis and Forecast to 2019 [Published by MarketsandMarkets] | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...

  • 360i Research
  • 99Strategy
  • Allied Market Research
  • Asia Market Information & Development Co.
  • Azoth Analytics
  • BioInformant
  • Black Swan Analysis
  • Canadean
  • CBR Pharma Insights
  • CRI
  • Current Analysis
  • Current Partnering
  • Daedal Research
  • Data bridge
  • Delve Insight
  • DPI Research
  • FirstWord Pharma
  • Future Market Insights
  • GBI Research
  • Global Data
  • Global Markets Direct
  • Global Research and Data Services GRDS
  • GMR Data
  • HeyReport
  • HongChun
  • HTStec
  • ICD Research
  • iGATE Research
  • IMARC
  • Industry ARC
  • Inkwood Research
  • IQ4I
  • Jain PharmaBiotech
  • Kelly Scientific
  • La Merie
  • Lifescience Intellipedia
  • LP Information
  • Market Data Forecast
  • Market Research Future
  • Marketline
  • MarketsandMarkets
  • McDerson
  • MedMarket Diligence
  • Meticulous Research
  • MicroMarketMonitor
  • MIReports
  • Mordor Intelligence LLC
  • MP Advisors
  • Occams Business Research
  • Prof Research
  • Progressive Markets
  • ProGrow Pharma Partners
  • Renub
  • Research Impact
  • RNCOS
  • Rockville Research
  • S&P Consulting
  • StratisticsMRC
  • The Business Research Company
  • Triton Market Research
  • Venture Planning Group (VPG)